Founded in 1978, Disprofarma has established itself as Argentina’s largest medicine distributor and the undisputed leader in pharmaceutical logistics. The company was founded with the aim of providing a comprehensive solution for the marketing of medicinal products, and today represents more than 40 top-tier laboratories. With a model 30,000 m² facility located in Villa Soldati, City of Buenos Aires, the organization manages a state-of-the-art technological infrastructure that enables it to distribute more than 180 million units annually throughout the country.
Commercial offices
Pharmaceutical plant
34 Contracting Laboratories
US$45 million in revenue / year
200 million units distributed / year
400+ employees”
NEWS
ACTIVITIES
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
Based on production quality, research and development, and the efficiency of its technical and commercial service, Biogénesis – Bagó has become an international leader in animal health.
The distribution of pharmaceuticals is a key factor of this industry and a competitve advantage of the Bagó Group, with 3 distributors strategically located in Latin America and equipped with state-of-the-art technology.
Victoria Seguros, is a solid and responsible insurance company, with a vast track record and high reputation in the market. It offers a wide range of top quality products.
The pharmochemical production of active pharmaceutical ingredients from chemical inputs is carried out at the Grupo Bagó industrial plant, specifically designed for these types of processes.
ACTIVITIES
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
ACTIVITIES
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
Based on production quality, research and development, and the efficiency of its technical and commercial service, Biogénesis – Bagó has become an international leader in animal health.
The distribution of pharmaceuticals is a key factor of this industry and a competitve advantage of the Bagó Group, with 3 distributors strategically located in Latin America and equipped with state-of-the-art technology.
Victoria Seguros, is a solid and responsible insurance company, with a vast track record and high reputation in the market. It offers a wide range of top quality products.
The pharmochemical production of active pharmaceutical ingredients from chemical inputs is carried out at the Grupo Bagó industrial plant, specifically designed for these types of processes.
ACTIVITIES
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness
The pharmaceutical and biological products of the Bagó Group are internationally acknowledged due to their maximum quality and therapeutic effectiveness